TY - JOUR T1 - Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2020-001694corr1 VL - 9 IS - 10 SP - e001694corr1 A2 - , Y1 - 2021/10/01 UR - http://jitc.bmj.com/content/9/10/e001694corr1.abstract ER -